{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:32:10Z","timestamp":1787653930085,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00247-019-04529-8","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T09:04:50Z","timestamp":1571216690000},"page":"1545-1564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Kathleen M.","family":"McCarten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0236-7298","authenticated-orcid":false,"given":"Helen R.","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry L.","family":"Shulkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"4529_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/095952873201700106","volume":"17","author":"Hodgkin","year":"1832","unstructured":"Hodgkin (1832) On some morbid appearances of the absorbent glands and spleen. Med Chir Trans 17:68\u2013114","journal-title":"Med Chir Trans"},{"key":"4529_CR2","volume-title":"Hodgkin lymphoma","author":"RT Hoppe","year":"2007","unstructured":"Hoppe RT, Mauch PT, Armitage JO et al (2007) Hodgkin lymphoma. Lippincott Williams & Wilkins, Philadelphia"},{"key":"4529_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18832-9","volume-title":"Radiological imaging in hematological malignancies","author":"A Guermazi","year":"2004","unstructured":"Guermazi A (2004) Radiological imaging in hematological malignancies. Springer-Verlag, Berlin"},{"key":"4529_CR4","volume-title":"Hodgkin lymphoma","author":"A Gossman","year":"2007","unstructured":"Gossman A (2007) Anatomic imaging. In: Hoppe RT, Mauch PT, Armitage JO et al (eds) Hodgkin lymphoma. Lippincott Williams & Wilkins, Philadelphia"},{"key":"4529_CR5","doi-asserted-by":"crossref","unstructured":"Flerlage JE, Kelly KM, Beishuizen A et al (2017) Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer 64","DOI":"10.1002\/pbc.26421"},{"key":"4529_CR6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630\u20131636","journal-title":"J Clin Oncol"},{"key":"4529_CR7","first-page":"124","volume-title":"Hodgkin lymphoma","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Gospodarowicz MK (2007) Clinical evaluation and staging of Hodgkin lymphoma. In: Hoppe RT, Mauch PT, Armitage JO et al (eds) Hodgkin lymphoma. Lippincott Williams & Wilkins, Philadelphia, pp 124\u2013128"},{"key":"4529_CR8","doi-asserted-by":"crossref","unstructured":"Schwartz CL, Chen L, McCarten K et al (2017) Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 64","DOI":"10.1002\/pbc.26278"},{"key":"4529_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s00247-018-4197-6","volume":"48","author":"KM McCarten","year":"2018","unstructured":"McCarten KM, Metzger ML, Drachtman RA et al (2018) Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. Pediatr Radiol 48:1736\u20131744","journal-title":"Pediatr Radiol"},{"key":"4529_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood-2018-02-834465","volume":"132","author":"LJ Marks","year":"2018","unstructured":"Marks LJ, McCarten KM, Pei Q et al (2018) Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. Blood 132:1208\u20131211","journal-title":"Blood"},{"key":"4529_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1148\/radiographics.21.1.g01ja02161","volume":"21","author":"A Guermazi","year":"2001","unstructured":"Guermazi A, Brice P, de Kerviler EE et al (2001) Extranodal Hodgkin disease: spectrum of disease. Radiographics 21:161\u2013179","journal-title":"Radiographics"},{"key":"4529_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12149-014-0920-z","volume":"29","author":"HJ Adams","year":"2015","unstructured":"Adams HJ, Kwee TC, Fijnheer R et al (2015) Bone marrow FDG-PET\/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Ann Nucl Med 29:132\u2013137","journal-title":"Ann Nucl Med"},{"key":"4529_CR13","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1200\/JCO.2010.32.4996","volume":"29","author":"S Purz","year":"2011","unstructured":"Purz S, Mauz-Korholz C, Korholz D et al (2011) [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. J Clin Oncol 29:3523\u20133528","journal-title":"J Clin Oncol"},{"key":"4529_CR14","first-page":"256","volume-title":"Radiological imaging in hematological malignancies","author":"P Guillerman","year":"2004","unstructured":"Guillerman P, Parker BR (2004) Pediatric lymphoma. In: Guermazi A (ed) Radiological imaging in hematological malignancies. Springer-Verlag, Berlin, p 256"},{"key":"4529_CR15","first-page":"491","volume":"75","author":"G Del Rocio Estrada-Sanchez","year":"2007","unstructured":"Del Rocio Estrada-Sanchez G, Altamirano-Ley J, Ochoa-Carrillo FJ (2007) Normal variants and frequent pitfalls with (18)FDG PET\/CT study. Cir Cir 75:491\u2013497","journal-title":"Cir Cir"},{"key":"4529_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/pbc.20993","volume":"49","author":"H Bashir","year":"2007","unstructured":"Bashir H, Hudson MM, Kaste SC et al (2007) Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 49:666\u2013671","journal-title":"Pediatr Blood Cancer"},{"key":"4529_CR17","first-page":"xxiv","volume-title":"Principles and practice of pediatric oncology","author":"CE Allen","year":"2016","unstructured":"Allen CE, Kamdar KY, Bollard CM (2016) Malignant non-Hodgkin lymphomas in childhood. In: Pizzo PA, Poplack DG, Adamson PC et al (eds) Principles and practice of pediatric oncology. Wolters Kluwer, Philadelphia, p xxiv"},{"key":"4529_CR18","doi-asserted-by":"crossref","unstructured":"Evens AM, Winter JN, Gordon LI et al (2015) Non-Hodgkin lymphoma. Cancer Network website. http:\/\/www.cancernetwork.com\/cancer-management\/non-hodgkin-lymphoma . Accessed 27 Aug 2019","DOI":"10.1007\/978-3-319-13150-4"},{"key":"4529_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pcl.2014.09.010","volume":"62","author":"CE Allen","year":"2015","unstructured":"Allen CE, Kelly KM, Bollard CM (2015) Pediatric lymphomas and histiocytic disorders of childhood. Pediatr Clin N Am 62:139\u2013165","journal-title":"Pediatr Clin N Am"},{"key":"4529_CR20","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332\u2013339","journal-title":"Semin Oncol"},{"key":"4529_CR21","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","volume":"33","author":"A Rosolen","year":"2015","unstructured":"Rosolen A, Perkins SL, Pinkerton CR et al (2015) Revised international pediatric non-Hodgkin lymphoma staging system. J Clin Oncol 33:2112\u20132118","journal-title":"J Clin Oncol"},{"key":"4529_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.116.176511","volume":"58","author":"S Bakhshi","year":"2017","unstructured":"Bakhshi S, Bhethanabhotla S, Kumar R et al (2017) Posttreatment PET\/CT rather than interim PET\/CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma: a prospective study comparing PET\/CT with conventional imaging. J Nucl Med 58:577\u2013583","journal-title":"J Nucl Med"},{"key":"4529_CR23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1460-9592.2007.02279.x","volume":"17","author":"DL Anghelescu","year":"2007","unstructured":"Anghelescu DL, Burgoyne LL, Liu T et al (2007) Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Paediatr Anaesth 17:1090\u20131098","journal-title":"Paediatr Anaesth"},{"key":"4529_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/pbc.20702","volume":"48","author":"A Ng","year":"2007","unstructured":"Ng A, Bennett J, Bromley P et al (2007) Anaesthetic outcome and predictive risk factors in children with mediastinal tumours. Pediatr Blood Cancer 48:160\u2013164","journal-title":"Pediatr Blood Cancer"},{"key":"4529_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08880010500313561","volume":"23","author":"S Alavi","year":"2006","unstructured":"Alavi S, Arzanian MT, Abbasian MR, Ashena Z (2006) Tumor lysis syndrome in children with non-Hodgkin lymphoma. Pediatr Hematol Oncol 23:65\u201370","journal-title":"Pediatr Hematol Oncol"},{"key":"4529_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2967\/jnumed.116.181347","volume":"58","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Johnson PWM (2017) (18)F-FDG PET\/CT in lymphoma: has imaging-directed personalized medicine become a reality? J Nucl Med 58:1539\u20131544","journal-title":"J Nucl Med"},{"key":"4529_CR27","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048\u20133058","journal-title":"J Clin Oncol"},{"key":"4529_CR28","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","volume":"27","author":"C Furth","year":"2009","unstructured":"Furth C, Steffen IG, Amthauer H et al (2009) Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 27:4385\u20134391","journal-title":"J Clin Oncol"},{"key":"4529_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/pbc.20797","volume":"48","author":"HJ Meany","year":"2007","unstructured":"Meany HJ, Gidvani VK, Minniti CP (2007) Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 48:399\u2013402","journal-title":"Pediatr Blood Cancer"},{"key":"4529_CR30","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L et al (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 25:3746\u20133752","journal-title":"J Clin Oncol"},{"key":"4529_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"4529_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571\u2013578","journal-title":"J Clin Oncol"},{"key":"4529_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3109\/10428190903308072","volume":"50","author":"A Gallamini","year":"2009","unstructured":"Gallamini A, Fiore F, Sorasio R, Meignan M (2009) Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leuk Lymphoma 50:1761\u20131764","journal-title":"Leuk Lymphoma"},{"key":"4529_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s00259-011-1741-0","volume":"38","author":"PY Le Roux","year":"2011","unstructured":"Le Roux PY, Gastinne T, Le Gouill S et al (2011) Prognostic value of interim FDG PET\/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. Eur J Nucl Med Mol Imaging 38:1064\u20131071","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR35","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"4529_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2009-08-234351","volume":"115","author":"SJ Horning","year":"2010","unstructured":"Horning SJ, Juweid ME, Schoder H et al (2010) Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 115:775\u2013777","journal-title":"Blood"},{"key":"4529_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Meignan M et al (2009) Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma 50:1257\u20131260","journal-title":"Leuk Lymphoma"},{"key":"4529_CR38","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, Qian W, Somer EJ et al (2010) Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 37:1824\u20131833","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149072","volume":"11","author":"R Kluge","year":"2016","unstructured":"Kluge R, Chavdarova L, Hoffmann M et al (2016) Inter-reader reliability of early FDG-PET\/CT response assessment using the Deauville scale after 2 cycles of intensive chemotherapy (OEPA) in Hodgkin's lymphoma. PLoS One 11:e0149072","journal-title":"PLoS One"},{"key":"4529_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdt533","volume":"25","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, de Keizer B et al (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25:921\u2013927","journal-title":"Ann Oncol"},{"key":"4529_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","volume":"41","author":"D Hasenclever","year":"2014","unstructured":"Hasenclever D, Kurch L, Mauz-Korholz C et al (2014) qPET \u2014 a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging 41:1301\u20131308","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR42","doi-asserted-by":"publisher","first-page":"122s","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50:122s\u2013150s","journal-title":"J Nucl Med"},{"key":"4529_CR43","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2967\/jnumed.114.147728","volume":"56","author":"WA Weber","year":"2015","unstructured":"Weber WA, Gatsonis CA, Mozley PD et al (2015) Repeatability of 18F-FDG PET\/CT in advanced non-small cell lung cancer: prospective assessment in 2 multicenter trials. J Nucl Med 56:1137\u20131143","journal-title":"J Nucl Med"},{"key":"4529_CR44","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00259-014-2879-3","volume":"41","author":"E Laffon","year":"2014","unstructured":"Laffon E, Marthan R (2014) Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology. Eur J Nucl Med Mol Imaging 41:2154","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR45","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s00259-017-3826-x","volume":"44","author":"R Kluge","year":"2017","unstructured":"Kluge R, Barrington S, Kurch L, Hasenclever D (2017) Reply to: Laffon and Marthan \"FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET\". Eur J Nucl Med Mol Imaging 44:2331\u20132332","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR46","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","volume":"41","author":"S Kanoun","year":"2014","unstructured":"Kanoun S, Rossi C, Berriolo-Riedinger A et al (2014) Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 41:1735\u20131743","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR47","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","volume":"128","author":"BD Cheson","year":"2016","unstructured":"Cheson BD, Ansell S, Schwartz L et al (2016) Refinement of the Lugano classification lymphoma response criteria in the era of immunomodulatory therapy. Blood 128:2489\u20132496","journal-title":"Blood"},{"key":"4529_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/10428194.2018.1488254","volume":"60","author":"A Castello","year":"2018","unstructured":"Castello A, Grizzi F, Qehajaj D et al (2018) (18)F-FDG PET\/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors. Leuk Lymphoma 60:367\u2013375","journal-title":"Leuk Lymphoma"},{"key":"4529_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2967\/jnumed.114.146290","volume":"56","author":"L Uslu","year":"2015","unstructured":"Uslu L, Donig J, Link M et al (2015) Value of 18F-FDG PET and PET\/CT for evaluation of pediatric malignancies. J Nucl Med 56:274\u2013286","journal-title":"J Nucl Med"},{"key":"4529_CR50","doi-asserted-by":"crossref","unstructured":"Bakhshi S, Radhakrishnan V, Sharma P et al (2012) Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET\/CT versus contrast-enhanced CT for evaluation \u2014 a prospective study. Radiology 262:956\u2013968","DOI":"10.1148\/radiol.11110936"},{"key":"4529_CR51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40336-017-0232-0","volume":"5","author":"SL Brady","year":"2017","unstructured":"Brady SL, Shulkin BL (2017) Dose optimization: a review of CT imaging for PET attenuation correction. Clin Transl Imaging 5:359\u2013371","journal-title":"Clin Transl Imaging"},{"key":"4529_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.semnuclmed.2017.01.002","volume":"47","author":"MT Parisi","year":"2017","unstructured":"Parisi MT, Bermo MS, Alessio AM et al (2017) Optimization of pediatric PET\/CT. Semin Nucl Med 47:258\u2013274","journal-title":"Semin Nucl Med"},{"key":"4529_CR53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2967\/jnumed.118.209916","volume":"59","author":"KK Wong","year":"2018","unstructured":"Wong KK, Brady SL, Doubrovin M et al (2018) Propranolol decreases 18F-fluorodeoxyglucose uptake in brown adipose tissue on pediatric oncology PET\/CT. J Nucl Med 59:310","journal-title":"J Nucl Med"},{"key":"4529_CR54","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2214\/AJR.10.6074","volume":"196","author":"MB Sammer","year":"2011","unstructured":"Sammer MB, Shulkin BL, Alessio A, Parisi MT (2011) Role of limited whole-body PET\/CT in pediatric lymphoma. AJR Am J Roentgenol 196:1047\u20131055","journal-title":"AJR Am J Roentgenol"},{"key":"4529_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00247-011-2228-7","volume":"42","author":"SE Sharp","year":"2012","unstructured":"Sharp SE, Gelfand MJ, Absalon MJ (2012) Altered FDG uptake patterns in pediatric lymphoblastic lymphoma patients receiving induction chemotherapy that includes very high dose corticosteroids. Pediatr Radiol 42:331\u2013336","journal-title":"Pediatr Radiol"},{"key":"4529_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","volume":"37","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Kotb M et al (2010) Role of PET\/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging 37:319\u2013329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR57","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.clml.2017.06.010","volume":"17","author":"P Vishnu","year":"2017","unstructured":"Vishnu P, Wingerson A, Lee M et al (2017) Utility of bone marrow biopsy and aspirate for staging of diffuse large B cell lymphoma in the era of positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-deoxyglucose integrated with computed tomography. Clin Lymphoma Myeloma Leuk 17:631\u2013636","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4529_CR58","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2010","unstructured":"Karantanis D, Durski JM, Lowe VJ et al (2010) 18F-FDG PET and PET\/CT in Burkitt's lymphoma. Eur J Radiol 75:e68\u2013e73","journal-title":"Eur J Radiol"},{"key":"4529_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fmed.2014.00054","volume":"1","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eugene T, Couec ML et al (2014) Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med 1:54","journal-title":"Front Med"},{"key":"4529_CR60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MPH.0b013e3182281c54","volume":"34","author":"M Otto","year":"2012","unstructured":"Otto M, Shulkin BL, Kundu M et al (2012) Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma. J Pediatr Hematol Oncol 34:232\u2013235","journal-title":"J Pediatr Hematol Oncol"},{"key":"4529_CR61","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","volume":"85","author":"HJA Adams","year":"2016","unstructured":"Adams HJA, Kwee TC (2016) Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis. Eur J Radiol 85:1963\u20131970","journal-title":"Eur J Radiol"},{"key":"4529_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jnci.2016.03.003","volume":"28","author":"H Abdel Rahman","year":"2016","unstructured":"Abdel Rahman H, Sedky M, Hamoda A et al (2016) Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin\u2019s lymphoma. CCHE experience. J Egypt Natl Canc Inst 28:95\u201399","journal-title":"J Egypt Natl Canc Inst"},{"key":"4529_CR63","unstructured":"Children\u2019s Oncology Group (2015) AALL1231: a phase III randomized trial investigating Bortezomib on a modified augmented BFM (ABFM) backbone in newly diagnosed T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LLy). https:\/\/www.childrensoncologygroup.org\/aall1231 . Accessed 25 Apr 2019"},{"key":"4529_CR64","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1007\/s00259-017-3824-z","volume":"45","author":"H Nadel","year":"2018","unstructured":"Nadel H, Etchebehere E, Cerci J et al (2018) Validation of standardized interpretation criteria for early response evaluation with (18)FDG-PET\/CT in pediatric lymphoma \u2014 a report on an IAEA multicenter prospective study. Eur J Nucl Med Mol Imaging 45:S187\u2013S187","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4529_CR65","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2967\/jnumed.118.222299","volume":"60","author":"JJ Cerci","year":"2019","unstructured":"Cerci JJ, Etchebehere EC, Nadel H et al (2019) Is true whole-body (18)F-FDG PET\/CT required in pediatric lymphoma? An IAEA multicenter prospective study. J Nucl Med 60:1087\u2013s1093","journal-title":"J Nucl Med"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-019-04529-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T22:53:54Z","timestamp":1721861634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-019-04529-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1007\/s00247-019-04529-8","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}